Related Experiment Video
Updated: Aug 10, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Pick's disease associated with the novel Tau gene mutation K369I
M Neumann1, W Schulz-Schaeffer, R A Crowther
1Institute of Neuropathology, Ludwig-Maximilians-University, Munich, Germany.
Annals of Neurology
|October 17, 2001
Summary
A novel Tau gene mutation, K369I, causes frontotemporal dementia with Pick's disease-like pathology. This genetic variant impairs tau protein function, leading to neurodegeneration and characteristic tau deposits.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Mutations in the Tau gene are linked to frontotemporal dementia and tau protein aggregation.
- Pick's disease is a neurodegenerative disorder characterized by specific tau pathology.
Purpose of the Study:
- To investigate the role of a novel Tau gene mutation (K369I) in a patient presenting with Pick's disease-like neuropathology.
- To characterize the biochemical and pathological effects of the K369I mutation on tau protein.
Main Methods:
- Clinical and postmortem neuropathological examination of a patient with a K369I Tau mutation.
- Immunoblot analysis of sarkosyl-insoluble tau and isolation of tau filaments.
- Biochemical assays using recombinant tau proteins with the K369I mutation.
Main Results:
- The patient exhibited clinical symptoms and neuropathological findings (Pick bodies, Pick cells) indistinguishable from sporadic Pick's disease.
- Immunoblotting revealed 3- and 4-repeat tau isoforms, and tau filaments showed abnormal morphology.
- Recombinant K369I mutant tau demonstrated reduced microtubule assembly promotion.
Conclusions:
- The K369I mutation in the Tau gene can induce a neurodegenerative disease presenting with the neuropathology of Pick's disease.
- The mutation likely causes disease by generating aberrant tau protein that readily forms filaments.
- This finding expands the spectrum of tauopathies associated with Tau gene mutations.
More Related Videos
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

